Supplementary Figure S4 from Preclinical Activity of Abemaciclib Alone or in Combination with Antimitotic and Targeted Therapies in Breast Cancer

Authors :: Dennis J. Slamon
Colleen Mockbee
Sara Hurvitz
Erika von Euw
Ondrej Kalous
Christophe Marchal
Ann Mc Nulty
Josh Thomas
Kevin Chau
Tong Luo
Richard Beckmann
Dylan Conklin
Neil O'Brien
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Abemaciclib has activity in xenograft models of triple negative breast cancer with intact Rb-signaling

Full Text Access

Tools